Citations

Mayo Clinic

Showing 10 of 108602 citations.

Emergency Medical Services Support for Acute Ischemic Stroke Patients Receiving Thrombolysis at a Primary Stroke Center
Spencer, Byron R., Bobrow, Bentley J., Khan, Omar M. , Demaerschalk, Bart M.

Journal of brain disease | September 13, 2017 | Volume: 1 | Issue: No issue available | Pages: JCNSD.S2221

10.4137/jcnsd.s2221 | PMID 23818804 Get It

Background Emergency Medical Services (EMS) is a vital link in the overall chain of stroke survival. A Primary Stroke Center (PSC) relies heavily on the 9-1-1 response system along with the ability of EMS personnel to accurately diagnose acute stroke. Other critical elements include identifying time of symptom onset, providing pre-hospital care, selecting a destination PSC, and communicating estimated time of arrival (ETA). Purpose Our purpose was to evaluate the EMS component of thrombolysed acute ischemic stroke patient care at our PSC. Methods In a retrospective manner we retrieved electronic copies of the EMS incident reports for every thrombolysed ischemic stroke patient treated at our PSC from September 2001 to August 2005. The following data elements were extracted: location of victim, EMS agency, times of dispatch, scene, departure, emergency department (ED) arrival, recordings of time of stroke onset, blood pressure (BP), heart rate (HR), cardiac rhythm, blood glucose (BG), Glasgow Coma Scale (GCS), Cincinnati Stroke Scale (CSS) elements, emergency medical personnel field assessment, and transport decision making. Results Eighty acute ischemic stroke patients received thrombolysis during the study interval. Eighty-one percent arrived by EMS. Two EMS agencies transported to our PSC. Mean dispatch-to-scene time was 6 min, on-scene time was 16 min, transport time was 10 min. Stroke onset time was recorded in 68%, BP, HR, and cardiac rhythm each in 100%, BG in 81%, GCS in 100%, CSS in 100%, and acute stroke diagnosis was made in 88%. Various diagnostic terms were employed: cerebrovascular accident in 40%, unilateral weakness or numbness in 20%, loss of consciousness in 16%, stroke in 8%, other stroke terms in 4%. In 87% of incident reports there was documentation of decision-making to transport to the nearest PSC in conjunction with pre-notification. Conclusion The EMS component of thrombolysed acute ischemic stroke patients care at our PSC appeared to be very good overall. Diagnostic accuracy was excellent, field assessment, decision-making, and transport times were very good. There was still room for improvement in documentation of stroke onset and in employment of a common term for acute stroke.
Introduction to Journal of Brain Disease
Demaerschalk, Bart M.

Journal of brain disease | September 13, 2017 | Volume: 1 | Issue: No issue available | Pages: 117957352020000

10.1177/117957352020000101 Get It

Review article: next‐generation transformative advances in the pathogenesis and management of autoimmune hepatitis
Czaja, Albert J. , Czaja, A J

Alimentary Pharmacology & Therapeutics | September 13, 2017 | Volume: 46 | Issue: 10 | Pages: 920-937

10.1111/apt.14324 | PMID 28901565 Get It

SummaryBackgroundAdvances in autoimmune hepatitis that transform current concepts of pathogenesis and management can be anticipated as products of ongoing investigations driven by unmet clinical needs and an evolving biotechnology.AimTo describe the advances that are likely to become transformative in autoimmune hepatitis, based on the direction of current investigations.MethodsPertinent abstracts were identified in PubMed by multiple search terms. Full‐length articles were selected for review, and a secondary bibliography was developed. The discovery process was repeated, and a tertiary bibliography was identified. The number of abstracts reviewed was 2830, and the number of full‐length articles reviewed exceeded 150.ResultsRisk‐laden allelic variants outside the major histocompatibility complex (rs3184504, r36000782) are being identified by genome‐wide association studies, and their gene products are potential therapeutic targets. Epigenetic changes associated with environmental cues can enhance the transcriptional activity of genes, and chromatin re‐structuring and antagonists of noncoding molecules of ribonucleic acid are feasible interventions. The intestinal microbiome is a discovery field for microbial products and activated immune cells that may translocate to the periphery and respond to manipulation. Epidemiological studies and controlled interview‐based surveys may implicate environmental and xenobiotic factors that warrant evidence‐based changes in lifestyle, and site‐directed molecular and cellular interventions promise to change the paradigm of treatment from one of blanket immunosuppression.ConclusionsAdvances in genetics, epigenetics, pathophysiology, epidemiology, and site‐directed molecular and cellular interventions constitute the next generation of transformative advances in autoimmune hepatitis.
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease
Yamazaki, Yu , Kanekiyo, Takahisa , Yamazaki, Yu

International Journal of Molecular Sciences | September 13, 2017 | Volume: 18 | Issue: 9 | Pages: 1965

10.3390/ijms18091965 | PMID 28902142 Get It

Brain capillary endothelial cells form the blood-brain barrier (BBB), which is covered with basement membranes and is also surrounded by pericytes and astrocyte end-feet in the neurovascular unit. The BBB tightly regulates the molecular exchange between the blood flow and brain parenchyma, thereby regulating the homeostasis of the central nervous system (CNS). Thus, dysfunction of the BBB is likely involved in the pathogenesis of several neurological diseases, including Alzheimer’s disease (AD). While amyloid-β (Aβ) deposition and neurofibrillary tangle formation in the brain are central pathological hallmarks in AD, cerebrovascular lesions and BBB alteration have also been shown to frequently coexist. Although further clinical studies should clarify whether BBB disruption is a specific feature of AD pathogenesis, increasing evidence indicates that each component of the neurovascular unit is significantly affected in the presence of AD-related pathologies in animal models and human patients. Conversely, since some portions of Aβ are eliminated along the neurovascular unit and across the BBB, disturbing the pathways may result in exacerbated Aβ accumulation in the brain. Thus, current evidence suggests that BBB dysfunction may causatively and consequently contribute to AD pathogenesis, forming a vicious cycle between brain Aβ accumulation and neurovascular unit impairments during disease progression.
Gene Variant of the Bradykinin B2 Receptor Influences Pulmonary Arterial Pressures in Heart Failure Patients
Olson, Thomas P. , Bailey, Kent R. , Wood, Christina M., Johnson, Bruce D. , Frantz, Robert P. , Turner, Stephen T.

Clinical medicine. Circulatory, respiratory and pulmonary medicine | September 13, 2017 | Volume: 3 | Issue: No issue available | Pages: CCRPM.S2147

10.4137/ccrpm.s2147 Get It

Background Pulmonary arterial pressure (PAP) varies considerably in heart failure (HF) despite similar degrees of left ventricular (LV) dysfunction. Bradykinin alters vascular tone and common variations in the kinin B2 receptor (BDKRB2) gene exists. We hypothesized that genetic variation in this receptor would influence PAP in HF. Methods 131 HF patients (>1yr history systolic HF), without COPD, not currently smoking, BMI < 40, without atrial fibrillation completed the study which included a blood draw for genotyping and neurohormones (ACE, A-II, Bradykinin, ANP, BNP, and catecholamines), an echocardiogram for cardiac function and systolic PAP (PAPsys). Results Mean LVEF was 29% ∓ 12%, NYHA class 2 ∓ 1, age 56 ∓ 12 yr, BMI 28 ∓ 5 kg/m 2 . Forty-six patients (35%) were homozygous for the +9 allele, 58 (44%) were heterozygous (+9/-9) and 27 (21%) were homozygous for the -9 allele of the BDKRB2. PAPsys averaged 42 ∓ 13, 38 ∓ 12, and 35 ∓ 11 mmHg for +9/+9, +9/-9 and -9/-9, respectively (p = 0.03). There was a trend towards gene effect for plasma ACE with the highest values in +9/+9 and lowest in -9/-9 patients (9.5 ∓ 10.7, 7.1 ∓ 8.7, and 5.4 ∓ 6.4 U/L, respectively, p = 0.06). There were no differences in plasma bradykinin or A-II, LVEF, or NYHA across genotypes. Conclusion These data suggest the +9/+9 polymorphism of the BDKRB2 receptor influences pulmonary vascular tone in stable HF.
The Usefulness of Submaximal Exercise Gas Exchange in Pulmonary Arterial Hypertension: A Case Series
Woods, Paul R., Johnson, Bruce D. , Frantz, Robert P.

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | September 13, 2017 | Volume: 4 | Issue: No issue available | Pages: 117954842020100

10.1177/117954842020100402 Get It

Introduction Submaximal exercise gas exchange may be a useful tool to track responses to therapy in pulmonary arterial hypertension (PAH) patients. Methods Three patients diagnosed with idiopathic PAH, on differing therapies, were included. Standard clinical tests (echocardiography; 6 minute walk) were performed pre and 3-5 months after treatment. Gas exchange was measured during 3 minutes of step exercise at both time points. Results Gas exchange variables, end tidal CO 2 (P ET CO 2 ) and the ratio of ventilation to CO 2 production (V E /VCO 2 ), during submaximal exercise were able to track patient responses to therapy over a 3-5 month period. Two patients demonstrated positive improvements, with an increased P ET CO 2 and decreased V E /VCO 2 during light exercise, in response to an altered therapeutic regime. The third patient had a worsening of gas exchange (decreased P ET CO 2 and increased V E /VCO 2 ) following no changes in the medical regime from the baseline visit. Conclusion Gas exchange variables measured during light submaximal exercise, such as P ET CO 2 and V E /VCO 2 , may be able to better detect small changes in functional status following treatment and could, therefore, be a useful tool to track disease severity in PAH patients. Further study is required to determine the clinical usefulness of these gas exchange variables.
Measuring achievement goal motivation, mindsets and cognitive load: validation of three instruments’ scores
Cook, David A. , Castillo, Richmond , Gas, Becca L. , Castillo, Richmond M, Gas, Becca, Artino, Anthony R.

Medical Education | September 13, 2017 | Volume: 51 | Issue: 10 | Pages: 1061-1074

10.1111/medu.13405 | PMID 28901645 Get It

Objective Measurement of motivation and cognitive load has potential value in health professions education. Our objective was to evaluate the validity of scores from Dweck's Implicit Theories of Intelligence Scale ( ITIS ), Elliot's Achievement Goal Questionnaire‐Revised ( AGQ ‐R) and Leppink's cognitive load index ( CLI ). Methods This was a validity study evaluating internal structure using reliability and factor analysis, and relationships with other variables using the multitrait‐multimethod matrix. Two hundred and thirty‐two secondary school students participated in a medical simulation‐based training activity at an academic medical center. Pre‐activity ITIS (implicit theory [mindset] domains: incremental, entity) and AGQ ‐R (achievement goal domains: mastery‐approach, mastery‐avoidance, performance‐approach, performance‐avoidance), post‐activity CLI (cognitive load domains: intrinsic, extrinsic, germane) and task persistence (self‐directed repetitions on a laparoscopic surgery task) were measured. Results Internal consistency reliability (Cronbach's alpha) was > 0.70 for all domain scores except AGQ ‐R performance‐avoidance (alpha 0.68) and CLI extrinsic load (alpha 0.64). Confirmatory factor analysis of ITIS and CLI scores demonstrated acceptable model fit. Confirmatory factor analysis of AGQ ‐R scores demonstrated borderline fit, and exploratory factor analysis suggested a three‐domain model for achievement goals (mastery‐approach, performance and avoidance). Correlations among scores from conceptually‐related domains generally aligned with expectations, as follows: ITIS incremental and entity, r = −0.52; AGQ ‐R mastery‐avoidance and performance‐avoidance, r = 0.71; mastery‐approach and performance‐approach, r = 0.55; performance‐approach and performance‐avoidance, r = 0.43; mastery‐approach and mastery‐avoidance, r = 0.36; CLI germane and extrinsic, r = −0.35; ITIS incremental and AGQ ‐R mastery‐approach, r = 0.34; ITIS incremental and CLI germane, r = 0.44; AGQ ‐R mastery‐approach and CLI germane, r = 0.48 (all p < 0.001). We found no correlation between the number of task repetitions (i.e. persistence) and mastery‐approach scores, r = −0.01. Conclusions ITIS and CLI scores had appropriate internal structures and relationships with other variables. AGQ ‐R scores fit a three‐factor (not four‐factor) model that collapsed avoidance into one domain, although relationships of other variables with the original four domain scores generally aligned with expectations. Mastery goals are positively correlated with germane cognitive load.
VV-ECMO–Assisted High-Risk Endobronchial Stenting as Rescue for Asphyxiating Mediastinal Mass
Nokes, Brandon , Vaszar, Laszlo T. , Jahanyar, Jama , Swanson, Karen L., Vaszar, Laszlo

Journal of Bronchology & Interventional Pulmonology | September 12, 2017 | Volume: 25 | Issue: 2 | Pages: 144-147

10.1097/lbr.0000000000000435 | PMID 28906275 Get It

The use of venovenous extracorporeal membrane oxygenation (VV-ECMO) has traditionally been limited to a narrow set of clinical circumstances, such as acute hypoxic respiratory failure, submassive pulmonary embolism, and cardiopulmonary collapse. Within the pediatric population, there have been cases of VV-ECMO in the context of extrinsic airway compression by a mediastinal mass, typically in the setting of either a lymphoma or germ cell tumors. However, the use of VV-ECMO for adults with extrinsic airway compression is comparatively limited. More specifically, VV-ECMO has been used as a bridge for tracheal reconstruction in both children and adults. Although, it has not been used in adults in the context of palliative endobronchial stent placement. We present a case of a 49-year-old woman with refractory multiple myeloma and extramedullary plasmacytoma presenting with acute hypoxic respiratory failure from extrinsic airway compression by a mediastinal plasmacytoma. We were able to use VV-ECMO to assist with endobronchial stent placement, followed by radiation therapy, and ultimately hospital discharge. In this article, we also review the literature surrounding VV-ECMO for extrinsic airway compression.
Young woman with segmental colitis
Anderson, Bradley W., Sweetser, Seth , Imam, Zaid

Gut | September 12, 2017 | Volume: 67 | Issue: 8 | Pages: 1399-1474

10.1136/gutjnl-2017-315122 | PMID 28899985 Get It

TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup
Labbé, David P. , Sweeney, Christopher J. , Galbo, Phillip M. , Wadosky, Kristine M. , Ku, Sheng‐Yu , Sjöström, Martin , Alshalalfa, Mohammed , Erho, Nicholas , Karnes, R. Jeffrey , Schaeffer, Edward M. , Jenkins, Robert B. , Ross, Ashley E. , Bowden, Michaela , Huang, Ying , Gray, Kathryn P. , Feng, Felix Y. , Spratt, Daniel E. , Goodrich, David W. , Ellis, Leigh , Spratt, Daniel E , Sweeney, Christopher , Brown, Myles , Rosario, Spencer R. , Davicioni, Elai , Den, Robert B. , Eng, Kevin H.

Clinical Cancer Research | September 12, 2017 | Volume: 23 | Issue: 22 | Pages: 7072-7083

10.1158/1078-0432.ccr-17-0413 | PMID 28899973 Get It

Abstract Purpose: Current clinical parameters do not stratify indolent from aggressive prostate cancer. Aggressive prostate cancer, defined by the progression from localized disease to metastasis, is responsible for the majority of prostate cancer–associated mortality. Recent gene expression profiling has proven successful in predicting the outcome of prostate cancer patients; however, they have yet to provide targeted therapy approaches that could inhibit a patient's progression to metastatic disease. Experimental Design: We have interrogated a total of seven primary prostate cancer cohorts (n = 1,900), two metastatic castration-resistant prostate cancer datasets (n = 293), and one prospective cohort (n = 1,385) to assess the impact of TOP2A and EZH2 expression on prostate cancer cellular program and patient outcomes. We also performed IHC staining for TOP2A and EZH2 in a cohort of primary prostate cancer patients (n = 89) with known outcome. Finally, we explored the therapeutic potential of a combination therapy targeting both TOP2A and EZH2 using novel prostate cancer–derived murine cell lines. Results: We demonstrate by genome-wide analysis of independent primary and metastatic prostate cancer datasets that concurrent TOP2A and EZH2 mRNA and protein upregulation selected for a subgroup of primary and metastatic patients with more aggressive disease and notable overlap of genes involved in mitotic regulation. Importantly, TOP2A and EZH2 in prostate cancer cells act as key driving oncogenes, a fact highlighted by sensitivity to combination-targeted therapy. Conclusions: Overall, our data support further assessment of TOP2A and EZH2 as biomarkers for early identification of patients with increased metastatic potential that may benefit from adjuvant or neoadjuvant targeted therapy approaches. Clin Cancer Res; 23(22); 7072–83. ©2017 AACR.